YOLFTbeta
Procept Biorobotics Corp

Procept Biorobotics Corp

PRCT · NASDAQ · Healthcare / Medical Devices

23.80USD+0.29 (+1.23%)

Price History

Full chart

Market Stats

Previous Close23.51
Open23.65
Day Range23.24 – 24.14
52-Week Range16.67 – 38.11
Volume1.68M
Market Cap985.11M
P/E (TTM)0.00
Forward P/E0.00
EPS-1.95
Dividend Yield0.00%
Beta0.90
50-Day Avg19.96
200-Day Avg25.25

About

PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. The company also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Larry L. Wood
  • Employees888
  • Headquarters150 Baytech Drive, San Jose, CA, United States, 95134, USA
  • Websitehttps://www.procept-biorobotics.com

Leadership

  • Mr. Larry L. WoodPresident, CEO & Director · b. 1966
  • Mr. Kevin WatersExecutive VP & CFO · b. 1977
  • Ms. Alaleh NouriEVP, Chief Legal Officer & Corporate Secretary · b. 1979
  • Mr. Christofer ChristoforouExecutive Vice President of Operations · b. 1970
  • Mr. Barry TemplinExecutive VP & CTO
  • Mr. Matthew James Bacso C.F.A.Vice President of Investor Relations
  • Ms. Pooja Sharma RaoExecutive VP and Chief Strategy & Marketing Officer
  • Ms. Stacey L. PorterExecutive VP & Chief People Officer · b. 1975
  • Mr. Bijesh ChandranExecutive Vice President of Regulatory Affairs & Quality Assurance
  • Mr. Stephen J. McGillSenior VP & GM of International · b. 1962

Financials

Income Statement

Currency: USD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue6.17M7.72M34.47M75.01M136.19M224.50M308.05M
Growth (%)-+25.09%+346.72%+117.60%+81.55%+64.84%+37.22%
Cost of Revenue8.05M8.97M18.61M37.93M65.14M87.40M111.83M
Gross Profit-1.89M-1.25M15.87M37.09M71.05M137.10M196.23M
Gross Margin-30.56%-16.26%46.02%49.44%52.17%61.07%63.70%
Operating Expense41.66M46.55M70.03M117.81M180.22M233.71M300.08M
Operating Income-43.55M-47.80M-54.16M-80.72M-109.17M-96.61M-103.86M
Operating Margin-705.95%-619.44%-157.12%-107.61%-80.16%-43.04%-33.71%
EBITDA-39.76M-44.90M-50.72M-79.13M-98.09M-82.00M-85.41M
EBITDA Margin-644.46%-581.81%-147.13%-105.49%-72.03%-36.52%-27.72%
Net Income-41.98M-53.02M-59.85M-87.15M-105.90M-91.41M-95.57M
Net Income Margin-680.42%-687.04%-173.62%-116.18%-77.76%-40.72%-31.02%
R&D13.15M16.27M18.99M28.98M48.45M62.30M71.28M
R&D as % of Total Revenue213.11%210.90%55.10%38.63%35.57%27.75%23.14%
Interest Expense724.00K5.26M5.81M5.18M4.00M4.18M3.59M
Interest Expense % of Total Revenue11.74%68.17%16.85%6.91%2.93%1.86%1.16%

Balance Sheet

Currency: USD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets61.99M125.97M337.02M309.33M404.72M534.02M508.08M
Total Liabilities32.76M65.01M69.93M112.26M123.97M131.80M142.21M
Total Equity29.23M60.96M267.09M197.07M280.75M402.22M365.87M
Cash42.02M100.13M304.32M222.64M257.22M333.73M286.50M
Total Debt23.22M54.76M54.10M77.32M79.20M80.25M78.48M
Net Debt-18.80M-45.37M-250.22M-145.32M-178.02M-253.47M-208.02M

Cash Flow

Currency: USD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-43.82M-48.34M-57.33M-80.38M-108.00M-99.21M-48.98M
Investing Cash Flow43.15M-233.00K-592.00K-2.65M-25.21M-4.41M-9.36M
Financing Cash Flow26.53M106.77M262.12M3.61M167.79M180.13M11.19M
Capital Expenditure7.61M233.00K592.00K2.65M25.21M4.41M9.36M
Free Cash Flow-51.43M-48.58M-57.93M-83.03M-133.21M-103.62M-58.34M
FCF to OCF117.37%100.48%101.03%103.30%123.34%104.44%119.10%

Earnings

Report DateMar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 16, 2021Nov 5, 2021Mar 8, 2022May 5, 2022Aug 5, 2022Nov 4, 2022Feb 28, 2023Apr 27, 2023Jul 27, 2023Nov 1, 2023Feb 27, 2024May 1, 2024Aug 1, 2024Oct 28, 2024Feb 25, 2025Apr 24, 2025Aug 6, 2025Nov 4, 2025Mar 3, 2026Apr 29, 2026Aug 4, 2026Nov 3, 2026
EPS Estimate0.000.000.000.000.000.00-0.40-0.42-0.39-0.47-0.48-0.52-0.54-0.58-0.56-0.52-0.45-0.56-0.52-0.49-0.34-0.49-0.41-0.42-0.32-0.56-0.46-0.39
EPS Actual-4.56-4.56-3.03-3.03-2.63-2.63-0.41-0.32-0.42-0.39-0.43-0.51-0.56-0.63-0.56-0.51-0.54-0.51-0.50-0.40-0.35-0.45-0.35-0.38-0.53-0.56-0.47-
Surprise-------2.50%23.81%-7.69%17.02%10.42%1.92%-3.70%-8.62%0.00%1.92%-20.00%8.93%3.85%18.37%-2.94%8.16%14.63%9.52%-63.43%0.00%-2.17%-
Timing------After-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursAfter-hours-After-hoursAfter-hours-

Key Statistics & Ratios

Market Cap985.11M
Enterprise Value886.53M
Trailing P/E0.00
Forward P/E0.00
Price / Sales2.90
Price / Book3.05
EPS-1.95
Book Value5.94
Revenue (TTM)337.34M
Gross Profit (TTM)213.75M
EBITDA-110.08M
Profit Margin-32.54%
Operating Margin-32.05%
Return on Equity-30.24%
Return on Assets-14.75%
Shares Outstanding57.27M
Shares Float55.81M
Beta0.90
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Buy
Based on 12 analystsTarget 21.64
  • Strong Buy
    6
  • Buy
    1
  • Hold
    4
  • Sell
    1

Ownership Breakdown

Institutions
100.40%
Insiders
3.48%
Retail / Other
0.00%

Top Institutional Holders

  • BlackRock Inc
    4.36M7.62%
  • T. Rowe Price Investment Management,Inc.
    3.27M5.72%
  • BNP Paribas Investment Partners SA
    3.09M5.39%
  • Vanguard Portfolio Management, LLC
    2.42M4.23%
  • Vanguard Capital Management, LLC
    2.40M4.19%
  • Chicago Capital LLC
    2.07M3.62%
  • Mackenzie Investments
    1.72M3.00%
  • State Street Corp
    1.53M2.67%
  • FMR Inc
    1.46M2.55%
  • Geode Capital Management, LLC
    1.36M2.38%
  • Wellington Management Company LLP
    1.27M2.22%
  • Federated Hermes Inc
    1.25M2.19%
  • Point72 Asset Management, L.P.
    1.13M1.97%
  • Frontier Capital Management CO Inc
    1.09M1.91%
  • Soleus Capital Management, L.P.
    1.00M1.75%

Top Fund Holders

  • Vanguard MStar Total Stk Mkt Idx Invest
    1.71M2.98%
  • iShares Russell 2000 ETF
    1.44M2.51%
  • T. Rowe Price Small-Cap Stock
    1.32M2.30%
  • Vanguard Small Cap Index
    1.24M2.17%
  • Janus Henderson Venture D
    1.07M1.87%